Evoke Pharma OverviewEvoke Pharma EBIT
EBIT (Earnings Before Interest and Taxes) analysis for EVOK.
Quarterly EBIT
-$1.14M
↑ 11.51% YoY
As of Sep 30, 2025
Annual EBIT (TTM)
-$4.83M
↑ 47.96% YoY
Trailing 12 months ending Sep 30, 2025
Evoke Pharma OverviewEBIT (Earnings Before Interest and Taxes) analysis for EVOK.
As of Sep 30, 2025
Trailing 12 months ending Sep 30, 2025